Deflazacort and Levothyroxine interaction

Deflazacort and Levothyroxine: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Deflazacort (EMFLAZA) label · effective 2025-11-13

Moderate

When concomitant administration of corticosteroids and levothyroxine is required, administration of corticosteroid should precede the initiation of levothyroxine therapy to reduce the risk of adrenal crisis.

Warnings and precautionsnames LevothyroxineView label on DailyMed
Moderate

In addition, patients with hypopituitarism, primary adrenal insufficiency or congenital adrenal hyperplasia, altered thyroid function, or pheochromocytoma may be at increased risk for adverse endocrine events.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Considerations for Use in Patients with Altered Thyroid Function Metabolic clearance of corticosteroids is decreased in hypothyroid patients and increased in hyperthyroid patients.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Changes in thyroid status of the patient may necessitate a dose adjustment of the corticosteroid.

Warnings and precautionsby drug classView label on DailyMed

From the Levothyroxine (Levothyroxine Sodium) label · effective 2024-07-10

Moderate

Failure to do so may precipitate an acute adrenal crisis when thyroid hormone therapy is initiated, due to increased metabolic clearance of glucocorticoids by thyroid hormone.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nictonic Acid These drugs may decrease serum TBG concentration.

Drug interactionsby drug classView label on DailyMed
Moderate

Glucocorticoids (e.g., Dexamethasone ≥ 4 mg/day) Short-term administration of large doses of glucocorticoids may decrease serum T 3 concentrations by 30% with minimal change in serum T 4 levels.

Drug interactionsby drug classView label on DailyMed
Moderate

However, long-term glucocorticoid therapy may result in slightly decreased T 3 and T 4 levels due to decreased TBG production (See above).

Drug interactionsby drug classView label on DailyMed
Moderate

Nephrosis, severe hypoproteinemia, severe liver disease, acromegaly, androgens, and corticosteroids decrease TBG concentration.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.